<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medalphabet</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский алфавит</journal-title><trans-title-group xml:lang="en"><trans-title>Medical alphabet</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2078-5631</issn><issn pub-type="epub">2949-2807</issn><publisher><publisher-name>ООО «Альфмед»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.33667/2078-5631-2024-4-7-11</article-id><article-id custom-type="elpub" pub-id-type="custom">medalphabet-3657</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Статьи</subject></subj-group></article-categories><title-group><article-title>Возможности проточной цитометрии, ПЦР и секвенирования в ранней диагностике активности атеросклероза (обзор литературы)</article-title><trans-title-group xml:lang="en"><trans-title>Possibilities of flow cytometry, PCR and sequencing in early diagnosis of atherosclerosis activity</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2592-6857</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ройтман</surname><given-names>А. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Roytman</surname><given-names>A. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ройтман Александр Польевич, д. м. н., профессор кафедры клинической лабораторной диагностики с курсом лабораторной иммунологии</p><p>Москва</p></bio><bio xml:lang="en"><p>Roitman Alexander P., DM Sci (habil.), professor at Dept of Clinical Laboratory Diagnostics with a course in Laboratory Immunology</p><p>Moscow</p></bio><email xlink:type="simple">aroitman@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8458-9702</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Маркина</surname><given-names>Н. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Markina</surname><given-names>N. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Маркина Надежда Сергеевна, ординатор кафедры клинической лабораторной диагностики с курсом лабораторной иммунологии</p><p>Москва</p></bio><bio xml:lang="en"><p>Markina Nadezhda S., resident of Dept of Clinical Laboratory Diagnostics with a course in laboratory immunology</p><p>Moscow</p></bio><email xlink:type="simple">nadezda.s.markina@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1537-7444</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Долгов</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Dolgov</surname><given-names>V. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Долгов Владимир Владимирович, д. м. н., профессор кафедры клинической лабораторной диагностики с курсом лабораторной иммунологии</p><p>Москва</p></bio><bio xml:lang="en"><p>Dolgov Vladimir V., Doctor of Medical Sciences, professor at Dept of Clinical Laboratory Diagnostics with a course in Laboratory Immunology</p><p>Moscow</p></bio><email xlink:type="simple">vvdolgov@inbox.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Russian Medical Academy of Continuous Professional Education</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>08</day><month>05</month><year>2024</year></pub-date><volume>0</volume><issue>4</issue><issue-title>Современная лаборатория (1)</issue-title><fpage>7</fpage><lpage>11</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Ройтман А.П., Маркина Н.С., Долгов В.В., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Ройтман А.П., Маркина Н.С., Долгов В.В.</copyright-holder><copyright-holder xml:lang="en">Roytman A.P., Markina N.S., Dolgov V.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.med-alphabet.com/jour/article/view/3657">https://www.med-alphabet.com/jour/article/view/3657</self-uri><abstract><p>Атеросклероз (АС) является многофакторным заболеванием, приводящим к повышению сердечно-сосудистых рисков. В настоящее время диагностика АС сводится к визуализирующим методам оценки атеросклеротической бляшки и лабораторным методам диагностики дислипидемий, которые не дают понимания активности процессов, происходящих в атеросклеротической бляшке. Цель данного обзора: обсудить потенциальные лабораторные маркёры активности АС. Важная роль в атерогенезе отводится макрофагам. Макрофаги имеют несколько фенотипов, определив которые можно сделать заключение об активности воспалительного процесса в бляшке. Не малую роль в развитии атеросклероза играют генетические маркёры, такие как микроРНК, кольцевые РНК и факторы, регулирующие их экспрессию. Перспективными для изучения данных маркёров являются методы проточной цитометрии, ПЦР и секвенирования. Маркёры активности атерогенеза являются необходимыми в диагностике, а также при выборе персонализированного лечения пациентов.</p></abstract><trans-abstract xml:lang="en"><p>Atherosclerosis (AS) is a multifactorial disease leading to increased cardiovascular risks. Currently, the diagnosis of AS is limited to imaging methods of atherosclerotic plaque assessment and laboratory methods of dyslipidemia diagnosis, which do not provide an understanding of the activity of processes occurring in the atherosclerotic plaque. The aim of this review: to generate potential markers of AS activity. Macrophages play an important role in atherogenesis. Macrophages have several phenotypes, determining which can be concluded about the activity of the inflammatory process in the plaque. Genetic markers, such as microRNAs, circular RNAs and factors regulating their expression, play an important role in the development of atherosclerosis. Methods of flow cytometry, PCR and sequencing are promising for studying these markers. Markers of atherogenesis activity are essential in diagnosis, as well as in the choice of personalized treatment of patients.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>атеросклероз</kwd><kwd>макрофаги</kwd><kwd>микроРНК</kwd><kwd>кольцевые РНК</kwd><kwd>цитометрии</kwd><kwd>ПЦР</kwd><kwd>секвенирование</kwd></kwd-group><kwd-group xml:lang="en"><kwd>atherosclerosis</kwd><kwd>macrophages</kwd><kwd>microRNAs</kwd><kwd>circular RNAs</kwd><kwd>cytometry</kwd><kwd>PCR</kwd><kwd>sequencing</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Кузьмичев Д. Е., Скребов Р. В. Клиника, морфология атеросклероза аорты с разрывом. Здравоохранение Югры: опыт и инновации. 2018; (4): 66–8. https://cyberleninka.ru/article/n/klinika-morfologiya-ateroskleroza-aorty-s-razryvom</mixed-citation><mixed-citation xml:lang="en">Kuzmichev D. E., Skrebov R. V. Clinic, morphology of aortic atherosclerosis with rupture. Healthcare of Ugra: experience and innovations. 2018; (4): 66–8. https://cyberleninka.ru/article/n/klinika-morfologiya-ateroskleroza-aorty-s-razryvom</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Кузнецов С. Н., Мушкамбаров Н. Н. Гистология, цитология и эмбриология. МИА (Медицинское информационное агентство); 2016: 640.</mixed-citation><mixed-citation xml:lang="en">Kuznetsov S. N., Mushkambarov N. N. Histology, cytologyandembryology. MIA (Medical Information Agency); 2016: 640.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Haverich A., Boyle E. C. Atherosclerosis Pathogenesis and Microvascular Dysfunction. Cham: Springer Nature; 2019. 130. https://doi.org/10.1007/978–3–030–20245–3</mixed-citation><mixed-citation xml:lang="en">Haverich A., Boyle E. C. Atherosclerosis Pathogenesis and Microvascular Dysfunction. Cham: Springer Nature; 2019. 130. https://doi.org/10.1007/978–3–030–20245–3</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Юрьева Э. А., Сухоруков В. С., Воздвиженская Е. С., Новикова Н. Н. Атеросклероз: гипотезыитеории. Российский вестник перинатологии и педиатрии. 2014; 59(3): 6–16. https://www.elibrary.ru/item.asp?id=21649590</mixed-citation><mixed-citation xml:lang="en">Yuryeva E. A., Sukhorukov V. S., Vozdvizhenskaya E. S., Novikova N. N. Atherosclerosis: hypothesesandtheories. Russian Bulletin of Perinatology and Pediatrics. 2014; 59(3): 6–16. https://www.elibrary.ru/item.asp?id=21649590</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Орищенко А. К., Гавриченко Е. П., Райкова К. А. Совеременные теории этиологии и патогенеза атеросклероза. Бюллетень медицинских интернет-конференций. 2021;11(3):57–57. ID: 2021–03–6-T-19461</mixed-citation><mixed-citation xml:lang="en">Orishchenko A. K., Gavrichenko E. P., Raikova K. A. Modern theories of the etiology and pathogenesis of atherosclerosis. Bulletin of Medical Internet Conferences. 2021; 11(3): 57–57. ID: 2021–03–6-T-19461</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Слепцов А. А. Клеточная гетерогенность и клональный гемопоэз клеток иммунной системы при атеросклерозе. Российскийкардиологическийжурнал. 2022;27(10):5228. https://doi.org/10.15829/1560–4071–2022–5228</mixed-citation><mixed-citation xml:lang="en">Sleptsov A. A. Cellular heterogeneity and clonal hematopoiesis of immune system cells in atherosclerosis. Russian Journal of Cardiology. 2022; 27(10): 5228. https://doi.org/10.15829/1560–4071–2022–5228</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Xu J., Lu X., Shi G. P. Vasa Vasorum in Atherosclerosis and Clinical Significance. Int J Mol Sci. 2015;16(5):11574–608. https://doi.org/10.3390/ijms160511574</mixed-citation><mixed-citation xml:lang="en">Xu J., Lu X., Shi G. P. Vasa Vasorum in Atherosclerosis and Clinical Significance. Int J Mol Sci. 2015;16(5):11574–608. https://doi.org/10.3390/ijms160511574</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Rademakers T., Douma K., Hackeng T. M., Post M. J., Sluimer J. C., Daemen идр. Plaque-Associated Vasa Vasorum in Aged Apolipoprotein E–Deficient Mice Exhibit Proatherogenic Functional Features In Vivo. Arteriosclerosis, Thrombosis, and Vascular Biology. 2013;33(2):249–56. https://doi.org/10.1161/ATVBAHA.112.300087</mixed-citation><mixed-citation xml:lang="en">Rademakers T., Douma K., Hackeng T. M., Post M. J., Sluimer J. C., Daemen идр. Plaque-Associated Vasa Vasorum in Aged Apolipoprotein E–Deficient Mice Exhibit Proatherogenic Functional Features In Vivo. Arteriosclerosis, Thrombosis, and Vascular Biology. 2013;33(2):249–56. https://doi.org/10.1161/ATVBAHA.112.300087</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Евдокименко А. Н., Куличенкова К. Н., Гулевская Т. С., Танашян М. М. Особенности регуляции ангиогенеза в атеросклеротических бляшках каротидного синуса на поздних стадиях развития атеросклероза. Российский физиологический журнал им И. М. Сеченова. 2022;108(5):649–66. https://doi.org/10.31857/S0869813922050041</mixed-citation><mixed-citation xml:lang="en">Evdokimenko A. N., Kulichenkova K. N., Gulevskaya T. S., Tanashyan M. M. Features of the regulation of angiogenesis in atherosclerotic plaques of the carotid sinus at the late stages of atherosclerosis development. Russian Physiological Journal named after I. M. Sechenov. 2022; 108(5): 649–66. https://doi.org/10.31857/S0869813922050041</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Погосова Н. В., Юферева Ю. М., Качанова Н. П., Метельская В. А., Колтунов И. Е., Воронина В. П., и др. Разработка алгоритма диагностики доклинического атеросклероза у пациентов из группы высокого риска развития сердечно-сосудистых заболеваний. Кардиология. 2020;60(2):75–82. https://doi.org/10.18087/cardio.2020.2.n964</mixed-citation><mixed-citation xml:lang="en">Pogosova N. V., YuferevaYu. M., Kachanova N. P., Metelskaya V. A., Koltunov I. E., Voronina V. P., etal. Development of an algorithm for diagnosing preclinical atherosclerosis in high-risk patients development of cardiovascular diseases. Cardiology. 2020; 60(2): 75–82. https://doi.org/10.18087/cardio.2020.2.n964</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Олейников В. Э., Салямова Л. И., Хромова А. А., Куприянова С. Н., Квасова О. Г., Илясов И. Б. Прогнозирование коронарного атеросклероза у пациентов с ишемической болезнью сердца молодого возраста с использованием неинвазивного биомаркера. Российский кардиологический журнал. 2020;25(12):3924. https://doi.org/10.15829/1560–4071–2020–3924</mixed-citation><mixed-citation xml:lang="en">Oleynikov V. E., Salyamova L. I., Khromova A. A., Kupriyanova S. N., Kvasova O. G., Ilyasov I. B. Prediction of coronary atherosclerosis in young patients with coronary heart disease using a non-invasive biomarker. Russian Journal of Cardiology. 2020; 25(12): 3924. https://doi.org/10.15829/1560–4071–2020–3924</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Kukharchuk V. V., Ezhov M. V., Sergienko I. V., Arabidze G. G., Balakhonova T. V., Gurevich V. S., идр. Eurasian association of cardiology (EAC)/ russian national atherosclerosis society (RNAS, russia) guidelines for the diagnosis and correction of dyslipidemia for the prevention and treatment of atherosclerosis (2020). Evrazijskij kardiologičeskij žurnal. 2020;(2):6–29. https://doi.org/10.38109/2225–1685–2020–2–6–29</mixed-citation><mixed-citation xml:lang="en">Kukharchuk V. V., Ezhov M. V., Sergienko I. V., Arabidze G. G., Balakhonova T. V., Gurevich V. S., идр. Eurasian association of cardiology (EAC)/ russian national atherosclerosis society (RNAS, russia) guidelines for the diagnosis and correction of dyslipidemia for the prevention and treatment of atherosclerosis (2020). Evrazijskij kardiologičeskij žurnal. 2020;(2):6–29. https://doi.org/10.38109/2225–1685–2020–2–6–29</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Abdulsalam M., Feng J. The composition of vulnerable plaque and its effect on arterial waveforms. Journal of the Mechanical Behavior of Biomedical Materials. 2021;119:104491. https://doi.org/10.1016/j.jmbbm.2021.104491</mixed-citation><mixed-citation xml:lang="en">Abdulsalam M., Feng J. The composition of vulnerable plaque and its effect on arterial waveforms. Journal of the Mechanical Behavior of Biomedical Materials. 2021;119:104491. https://doi.org/10.1016/j.jmbbm.2021.104491</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Biscetti F., Tinelli G., Rando M. M., Nardella E., Cecchini A. L., Angelini F., идр. Correction to: Association between carotid plaque vulnerability and high mobility group box-1 serum levels in a diabetic population. CardiovascDiabetol. 2021;20:184. https://doi.org/10.1186/s12933–021–01376–6</mixed-citation><mixed-citation xml:lang="en">Biscetti F., Tinelli G., Rando M. M., Nardella E., Cecchini A. L., Angelini F., идр. Correction to: Association between carotid plaque vulnerability and high mobility group box-1 serum levels in a diabetic population. CardiovascDiabetol. 2021;20:184. https://doi.org/10.1186/s12933–021–01376–6</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Пигаревский П. В., Снегова В. А., Назаров П. Г. Макрофаги и их роль в дестабилизации атеросклеротической бляшки. Кардиология. 2019;59(4):88–91. https://doi.org/10.18087/cardio.2019.4.10254</mixed-citation><mixed-citation xml:lang="en">Pigarevsky P. V., Snegova V. A., Nazarov P. G. Macrophages and their role in the destabilization of atherosclerotic plaque. Cardiology. 2019;59(4):88–91. https://doi.org/10.18087/cardio.2019.4.10254</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Fadini G. P., Simoni F., Cappellari R., Vitturi N., Galasso S., Kreutzenberg S. V., идр. Pro-inflammatory monocyte-macrophage polarization imbalance in human hypercholesterolemia and atherosclerosis. Atherosclerosis. 2014;237(2):805–8. https://doi.org/10.1016/j.atherosclerosis.2014.10.106</mixed-citation><mixed-citation xml:lang="en">Fadini G. P., Simoni F., Cappellari R., Vitturi N., Galasso S., Kreutzenberg S. V., идр. Pro-inflammatory monocyte-macrophage polarization imbalance in human hypercholesterolemia and atherosclerosis. Atherosclerosis. 2014;237(2):805–8. https://doi.org/10.1016/j.atherosclerosis.2014.10.106</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Isali I., McClellan P., R. Wong T., Cingireddi S., Jain M., M. Anderson J., Hijaz A., Akkus O. In Vivo Delivery of M0, M1, and M2 Macrophage Subtypes via Genipin-Cross-Linked Collagen Biotextile. Tissue Engineering. 2022; Part A: 672–684. http://doi.org/10.1089/ten.tea.2021.0203</mixed-citation><mixed-citation xml:lang="en">Isali I., McClellan P., R. Wong T., Cingireddi S., Jain M., M. Anderson J., Hijaz A., Akkus O. In Vivo Delivery of M0, M1, and M2 Macrophage Subtypes via Genipin-Cross-Linked Collagen Biotextile. Tissue Engineering. 2022; Part A: 672–684. http://doi.org/10.1089/ten.tea.2021.0203</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Devaraj S., Jialal I. CRP Polarizes Human Macrophages to a M1 Phenotype and Inhibits Transformation to the M2 Phenotype. Arterioscler Thromb Vasc Biol. 2011;31(6):1397–402. https://doi.org/10.1161/ATVBAHA.111.225508</mixed-citation><mixed-citation xml:lang="en">Devaraj S., Jialal I. CRP Polarizes Human Macrophages to a M1 Phenotype and Inhibits Transformation to the M2 Phenotype. Arterioscler Thromb Vasc Biol. 2011;31(6):1397–402. https://doi.org/10.1161/ATVBAHA.111.225508</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Piekarska A., Pérès M., Toton M., Kulczycka M., Lewandowski K., Vergez F. Identification of circulating regulatory T lymphocytes with membrane markers – a new multiparameter flow cytometry protocol. Folia Histochemica et Cytobiologica. 2021;59(2):75–85. https://doi.org/10.5603/FHC.a2021.0014</mixed-citation><mixed-citation xml:lang="en">Piekarska A., Pérès M., Toton M., Kulczycka M., Lewandowski K., Vergez F. Identification of circulating regulatory T lymphocytes with membrane markers – a new multiparameter flow cytometry protocol. Folia Histochemica et Cytobiologica. 2021;59(2):75–85. https://doi.org/10.5603/FHC.a2021.0014</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Emini Veseli B., Perrotta P., De Meyer, Roth L., Van der Donckt C, Martinet W., идр. Animal models of atherosclerosis. European Journal of Pharmacology. 2017;816:3–13. https://doi.org/10.1016/j.ejphar.2017.05.010</mixed-citation><mixed-citation xml:lang="en">Emini Veseli B., Perrotta P., De Meyer, Roth L., Van der Donckt C, Martinet W., идр. Animal models of atherosclerosis. European Journal of Pharmacology. 2017;816:3–13. https://doi.org/10.1016/j.ejphar.2017.05.010</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Skogsberg J., Lundström J., Kovacs A., Nilsson R., Noori P., Maleki S., идр. Transcriptional Profiling Uncovers a Network of Cholesterol-Responsive Atherosclerosis Target Genes. PLoS Genet. 2008;4(3): e1000036. https://doi.org/10.1371/journal.pgen.1000036</mixed-citation><mixed-citation xml:lang="en">Skogsberg J., Lundström J., Kovacs A., Nilsson R., Noori P., Maleki S., идр. Transcriptional Profiling Uncovers a Network of Cholesterol-Responsive Atherosclerosis Target Genes. PLoS Genet. 2008;4(3): e1000036. https://doi.org/10.1371/journal.pgen.1000036</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Wang J., Kang Z., Liu Y., Li Z., Liu Y., Liu J. Identification of immune cell infiltration and diagnostic biomarkers in unstable atherosclerotic plaques by integrated bioinformatics analysis and machine learning. Front Immunol. 2022;13:956078. https://doi.org/10.3389/fimmu.2022.956078</mixed-citation><mixed-citation xml:lang="en">Wang J., Kang Z., Liu Y., Li Z., Liu Y., Liu J. Identification of immune cell infiltration and diagnostic biomarkers in unstable atherosclerotic plaques by integrated bioinformatics analysis and machine learning. Front Immunol. 2022;13:956078. https://doi.org/10.3389/fimmu.2022.956078</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Bardina M., Pawelzikc S. C., Lagrangea J., Mahdic A., Arnardottirc H., Regnaulta V., Feved B., Lacolleya P., Michela J. B., Merciera N., Back M. The resolvin D 2 – GPR 18 axis is expressed in human coronary atherosclerosis and transduces atheroprotection in apolipoprotein E deficient mice – ScienceDirect. https://doi.org/10.1016/j.bcp.2022.115075</mixed-citation><mixed-citation xml:lang="en">Bardina M., Pawelzikc S. C., Lagrangea J., Mahdic A., Arnardottirc H., Regnaulta V., Feved B., Lacolleya P., Michela J. B., Merciera N., Back M. The resolvin D 2 – GPR 18 axis is expressed in human coronary atherosclerosis and transduces atheroprotection in apolipoprotein E deficient mice – ScienceDirect. https://doi.org/10.1016/j.bcp.2022.115075</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Petri M. H., Laguna-Fernández A., Gonzalez-Diez M., Paulsson-Berne G., Hansson G. K., Bäck M. The role of the FPR 2/ALX receptor in atherosclerosis development and plaque stability. Cardiovasc Res. 2015;105(1):65–74. https://doi.org/10.1093/cvr/cvu224</mixed-citation><mixed-citation xml:lang="en">Petri M. H., Laguna-Fernández A., Gonzalez-Diez M., Paulsson-Berne G., Hansson G. K., Bäck M. The role of the FPR 2/ALX receptor in atherosclerosis development and plaque stability. Cardiovasc Res. 2015;105(1):65–74. https://doi.org/10.1093/cvr/cvu224</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Arnold K. A., Blair J. E., Paul J. D., Shah A. P., Nathan S., Alenghat F. J. Monocyte and Macrophage Subtypes as Paired Cell Biomarkers for Coronary Artery Disease. Exp Physiol. 2019;104(9):1343–52. https://doi.org/10.1113/EP087827</mixed-citation><mixed-citation xml:lang="en">Arnold K. A., Blair J. E., Paul J. D., Shah A. P., Nathan S., Alenghat F. J. Monocyte and Macrophage Subtypes as Paired Cell Biomarkers for Coronary Artery Disease. Exp Physiol. 2019;104(9):1343–52. https://doi.org/10.1113/EP087827</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Williams H, Cassorla G, Pertsoulis N, Patel V, Vicaretti M, Marmash N, et al. Human classical monocytes display unbalanced M1/M2 phenotype with increased atherosclerotic risk and presence of disease – International Angiology 2017;36(2):145–55. https://doi.org/10.23736/S0392–9590.16.03661–0</mixed-citation><mixed-citation xml:lang="en">Williams H, Cassorla G, Pertsoulis N, Patel V, Vicaretti M, Marmash N, et al. Human classical monocytes display unbalanced M1/M2 phenotype with increased atherosclerotic risk and presence of disease – International Angiology 2017;36(2):145–55. https://doi.org/10.23736/S0392–9590.16.03661–0</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Ridker P. M. From CRP to IL-6 to IL-1: Moving Upstream To Identify Novel Targets for Atheroprotection. Circ Res. 2016;118(1):145–56. https://doi.org/10.1161/CIRCRESAHA.115.306656</mixed-citation><mixed-citation xml:lang="en">Ridker P. M. From CRP to IL-6 to IL-1: Moving Upstream To Identify Novel Targets for Atheroprotection. Circ Res. 2016;118(1):145–56. https://doi.org/10.1161/CIRCRESAHA.115.306656</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Уткина Е. А., Афанасьева О. И., Покровский С. Н. С-реактивный белок: патогенетические свойства и возможная терапевтическая мишень. Российский кардиологический журнал. 2021;26(6):4138. https://doi.org/10.15829/1560–4071–2021–4138</mixed-citation><mixed-citation xml:lang="en">Utkina E. A., Afanasyeva O. I., Pokrovsky S. N. C-reactive protein: pathogenetic properties and a possible therapeutic target. Russian Journal of Cardiology. 2021;26(6):4138. https://doi.org/10.15829/1560–4071–2021–4138</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Vlad M. L., Manea S. A., Lazar A. G., RaicuM., MuresianH., SimionescuM., идр. Histone Acetyltransferase-Dependent Pathways Mediate Upregulation of NADPH Oxidase 5 in Human Macrophages under Inflammatory Conditions: A Potential Mechanism of Reactive Oxygen Species Overproduction in Atherosclerosis. Oxid Med Cell Longev. 2019; 3201062. https://doi.org/10.1155/2019/3201062</mixed-citation><mixed-citation xml:lang="en">Vlad M. L., Manea S. A., Lazar A. G., RaicuM., MuresianH., SimionescuM., идр. Histone Acetyltransferase-Dependent Pathways Mediate Upregulation of NADPH Oxidase 5 in Human Macrophages under Inflammatory Conditions: A Potential Mechanism of Reactive Oxygen Species Overproduction in Atherosclerosis. Oxid Med Cell Longev. 2019; 3201062. https://doi.org/10.1155/2019/3201062</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Chen L., Huan X., Gao X. D., Yu W. H., Xiao G. H., Li T. F., идр. Biological Functions of the DNA Glycosylase NEIL3 and Its Role in Disease Progression Including Cancer. Cancers (Basel). 2022;14(23):5722. https://doi.org/10.3390/cancers14235722</mixed-citation><mixed-citation xml:lang="en">Chen L., Huan X., Gao X. D., Yu W. H., Xiao G. H., Li T. F., идр. Biological Functions of the DNA Glycosylase NEIL3 and Its Role in Disease Progression Including Cancer. Cancers (Basel). 2022;14(23):5722. https://doi.org/10.3390/cancers14235722</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Liu M., Doublié S., Wallace S. S. Neil3, the final frontier for the DNA glycosylases that recognize oxidative damage. Mutat Res. 2013:4–11. https://doi.org/10.1016/j.mrf-mmm. 2012. 12. 003</mixed-citation><mixed-citation xml:lang="en">Liu M., Doublié S., Wallace S. S. Neil3, the final frontier for the DNA glycosylases that recognize oxidative damage. Mutat Res. 2013:4–11. https://doi.org/10.1016/j.mrf-mmm.2012.12.003</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Skarpengland T., Holm S., Scheffler K., Gregersen I., Dahl T. B., Suganthan R., идр. Neil3-dependent base excision repair regulates lipid metabolism and prevents atherosclerosis in Apoe-deficient mice. SciRep. 2016;6:28337. https://doi.org/10.1038/srep28337</mixed-citation><mixed-citation xml:lang="en">Skarpengland T., Holm S., Scheffler K., Gregersen I., Dahl T. B., Suganthan R., идр. Neil3-dependent base excision repair regulates lipid metabolism and prevents atherosclerosis in Apoe-deficient mice. SciRep. 2016;6:28337. https://doi.org/10.1038/srep28337</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Котляров С. Н., Котлярова А. А. Участие ABC-транспортеров в липидном обмене и патогенезе атеросклероза. Геныиклетки. 2020;15(3):22–8. https://doi.org/10.23868/202011003</mixed-citation><mixed-citation xml:lang="en">Kotlyarov S. N., Kotlyarova A. A. Participation of ABC transporters in lipid metabolism and the pathogenesis of atherosclerosis. Genes and cells. 2020; 15(3): 22–8. https://doi.org/10.23868/202011003</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Павлович С. Л. АТФ-связывающиетранспортныебелкисемейства abc (ATP-binding cassette transporters, abc). Номенклатура, структура, молекулярное разнообразие, функция, участие в функционировании системы биотрансформации ксенобиотиков. Труды Карельского научного центра Российской академии наук. 2020;(3):5–19. http://dx.doi.org/10.17076/eb1044</mixed-citation><mixed-citation xml:lang="en">Pavlovich S. L. ATP-binding cassette transporters (ATP-binding cassette transporters, abc) family proteins. Nomenclature, structure, molecular diversity, function, participation in the functioning of the xenobiotic biotransformation system. Proceedings of the Karelian Scientific Center of the Russian Academy of Sciences. 2020; (3): 5–19. http://dx.doi.org/10.17076/eb1044</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Peters L. J. F., Biessen E. A. L., Hohl M., Weber C., van der Vorst E. P. C., Santovito D. Small Things Matter: Relevance of MicroRNAs in Cardiovascular Disease. Front Physiol. 2020;11:793. https://doi.org/10.3389/fphys.2020.00793</mixed-citation><mixed-citation xml:lang="en">Peters L. J. F., Biessen E. A. L., Hohl M., Weber C., van der Vorst E. P. C., Santovito D. Small Things Matter: Relevance of MicroRNAs in Cardiovascular Disease. Front Physiol. 2020;11:793. https://doi.org/10.3389/fphys.2020.00793</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">He S, Wu C, Xiao J, Li D, Sun Z, Li M. Endothelial extracellular vesiclesmodulate the macrophage phenotype: Potentialimplications in atherosclerosis. Scand J Immunol. 2018; 87: e12648. https://doi.org/10.1111/sji.1264816.</mixed-citation><mixed-citation xml:lang="en">He S, Wu C, Xiao J, Li D, Sun Z, Li M. Endothelial extracellular vesiclesmodulate the macrophage phenotype: Potentialimplications in atherosclerosis. Scand J Immunol. 2018; 87: e12648. https://doi.org/10.1111/sji.1264816.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Panda A. C. Circular RNAs Act as miRNA Sponges. Circular RNAs: Biogenesis and Functions. Singapore: Springer. 2018: 67–79. https://doi.org/10.1007/978–981–13–1426–1_6</mixed-citation><mixed-citation xml:lang="en">Panda A. C. Circular RNAs Act as miRNA Sponges. Circular RNAs: Biogenesis and Functions. Singapore: Springer. 2018: 67–79. https://doi.org/10.1007/978–981–13–1426–1_6</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Alkan A. H., Akgül B. Endogenous miRNA Sponges. miRNomics: MicroRNA Biology and Computational Analysis. New York, NY: Springer US. 2022; 91–104. https://doi.org/10.1007/978–1–0716–1170–8_5</mixed-citation><mixed-citation xml:lang="en">Alkan A. H., Akgül B. Endogenous miRNA Sponges. miRNomics: MicroRNA Biology and Computational Analysis. New York, NY: Springer US. 2022; 91–104. https://doi.org/10.1007/978–1–0716–1170–8_5</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Montalto F. I., De Amicis F. Cyclin D 1 in Cancer: A Molecular Connection for Cell Cycle Control, Adhesion and Invasion in Tumor and Stroma. Cells 9. 2020;9(12):2648. https://doi.org/10.3390/cells9122648</mixed-citation><mixed-citation xml:lang="en">Montalto F. I., De Amicis F. Cyclin D 1 in Cancer: A Molecular Connection for Cell Cycle Control, Adhesion and Invasion in Tumor and Stroma. Cells 9. 2020;9(12):2648. https://doi.org/10.3390/cells9122648</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Yang L., Yang F., Zhao H., Wang M., Zhang Y. Circular RNA circCHFR Facilitates the Proliferation and Migration of Vascular Smooth Muscle via miR-370/FOXO1/Cyclin D 1 Pathway. Mol Ther Nucleic Acids. 2019;16:434–41. https://doi.org/10.1016/j.omtn.2019.02.028</mixed-citation><mixed-citation xml:lang="en">Yang L., Yang F., Zhao H., Wang M., Zhang Y. Circular RNA circCHFR Facilitates the Proliferation and Migration of Vascular Smooth Muscle via miR-370/FOXO1/Cyclin D 1 Pathway. Mol Ther Nucleic Acids. 2019;16:434–41. https://doi.org/10.1016/j.omtn.2019.02.028</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Yu H., Zhao L., Zhao Y., Fei J., Zhang W. Circular RNA circ_0029589 regulates proliferation, migration, invasion, and apoptosis in ox-LDL-stimulated VSMCs by regulating miR-424–5p/IGF2 axis. Vascular Pharmacology. 2020;135:106782. https://doi.org/10.1016/j.vph.2020.106782</mixed-citation><mixed-citation xml:lang="en">Yu H., Zhao L., Zhao Y., Fei J., Zhang W. Circular RNA circ_0029589 regulates proliferation, migration, invasion, and apoptosis in ox-LDL-stimulated VSMCs by regulating miR-424–5p/IGF2 axis. Vascular Pharmacology. 2020;135:106782. https://doi.org/10.1016/j.vph.2020.106782</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Guo D., Zhao Y., Wang N., You N., Zhu W., Zhang P., идр. GADD 45g acts as a novel tumor suppressor, and its activation suggests new combination regimens for the treatment of AML. Blood. 2021;138(6):464–79. https://doi.org/10.1182/blood.2020008229</mixed-citation><mixed-citation xml:lang="en">Guo D., Zhao Y., Wang N., You N., Zhu W., Zhang P., идр. GADD 45g acts as a novel tumor suppressor, and its activation suggests new combination regimens for the treatment of AML. Blood. 2021;138(6):464–79. https://doi.org/10.1182/blood.2020008229</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Li Y., Wang B. Circular RNA circCHFR downregulation protects against oxidized low-density lipoprotein-induced endothelial injury via regulation of microRNA-15b-5p/ growth arrest and DNA damage inducible gamma. Bioengineered. 2022; 13(2):4481–92. https://doi.org/10.1080/21655979.2022.2032967</mixed-citation><mixed-citation xml:lang="en">Li Y., Wang B. Circular RNA circCHFR downregulation protects against oxidized low-density lipoprotein-induced endothelial injury via regulation of microRNA-15b-5p/ growth arrest and DNA damage inducible gamma. Bioengineered. 2022; 13(2):4481–92. https://doi.org/10.1080/21655979.2022.2032967</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
